ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TNGX
#1968
Tango Therapeutics, Inc.
11.1
4
+0.81%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+0.81%
月次変化
-7.32%
6か月変化
+60.75%
1年の変化
+413.36%
以前の終値
11.0
5
Open
11.1
4
Bid
Ask
Low
11.1
4
High
11.1
4
ボリューム
136
マーケット
株
ヘルスケア
TNGX
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
107.42 M
108.11 M
108.39 M
111.26 M
134.59 M
—
Valuation ratios
Enterprise value
773.97 M
264.52 M
90.07 M
530.38 M
1.07 B
1.96 B
Price to earnings ratio
-6.64
-2.6
-1.14
-3.91
-9.23
-16.88
Price to sales ratio
18.89
8.02
3.63
23.03
14.68
49.37
Price to cash flow ratio
6.6
2.57
1.11
3.79
6.43
13.89
Price to book ratio
0.81
1.69
0.18
0.77
1.42
4.06
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.12
0.15
0.16
0.08
0.5
Return on equity %
0.13
0.19
0.24
0.29
0.1
0.82
Return on invested capital %
159.12
215.29
222.29
211.92
85.24
734.75
Gross margin %
100
100
100
100
100
400
Operating margin %
283.26
993.93
788.76
1 287.87
26.15
3 096.7
EBITDA margin %
—
—
—
—
—
—
Net margin %
251.29
915.21
739.54
1 221.41
29.52
2 905.68
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8
6.98
6.26
4.75
8.88
26.87
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.01
0.02
0.01
0.24
0.28
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.31
0.34
0.38
0.33
0.26
1.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
4.92
2.36
1.96
1.64
1.3
7.26
Net current asset value per share
2.77
2.44
2.04
1.72
1.39
7.59
Tangible book value per share
2.11
1.83
1.51
1.22
1.36
5.92
Working capital per share
2.43
2.09
1.71
1.36
1.23
6.39
Book value per share
2.11
1.83
1.51
1.22
1.36
5.92
ニュース
스티펠, 탱고 테라퓨틱스에 ’매수’ 등급 재확인
Stifel reiterates Tango Therapeutics stock rating at Buy
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Tango Therapeutics, 52주 신고가 경신: 13.5 USD
Tango Therapeutics stock hits 52-week high at 13.5 USD
미주호, Tango Therapeutics에 ’아웃퍼폼’ 등급 개시
Mizuho initiates Tango Therapeutics stock with outperform rating
Tango Therapeutics, 52주 신고가 경신, 주당 $13.47
Tango Therapeutics stock hits 52-week high at $13.47
Tango Therapeutics CFO, TNGX 주식 126,530달러 매도
Tango Therapeutics CFO sells $126,530 in TNGX stock
탱고 테라퓨틱스 이사, TNGX 주식 37만 4천 달러 매도